Modulation of adrenal aldosterone release by oxidative modification of low-density lipoprotein

Am J Hypertens. 2010 Oct;23(10):1061-8. doi: 10.1038/ajh.2010.118. Epub 2010 Jun 17.

Abstract

Background: Serum aldosterone is a causative factor for various metabolic and cardiovascular disorders. Low-density lipoprotein (LDL) is a major cholesterol source for aldosterone steroidogenesis; however, the effect of oxidative modification of LDL on aldosterone release is not known. We studied the effect of hypochlorite-oxidized LDL (oxLDL) on adrenal aldosterone secretion.

Methods: LDL (native LDL (natLDL)) was obtained from healthy volunteers and oxidatively modified in vitro. NCI-H295R cells were stimulated with natLDL and oxLDL, and the aldosterone release was quantified by radioimmunoassay. Molecular changes were studied with western blot analysis and quantitative RT-PCR analysis.

Results: NatLDL and oxLDL caused dose-dependent increase in aldosterone release up to threefold. However, the stimulatory effects of modified LDL on aldosterone secretion decreased with increasing degree of LDL oxidation. 24-h incubations with natLDL, mild- and medium-oxidized LDL sensitized the adrenocortical cells to subsequent angiotensin II (Ang II) stimulations by 2.9-, 2.8-, and 2.5-folds, respectively. Heavily oxidized LDL did not sensitize the cells to Ang II stimulations to a similar extent. At the molecular level, the ERK pathway was activated within a minute by both natLDL and oxLDL; however, oxLDL showed a stronger (2.75-fold at 1 and 15 min) and longer (15 min) activation of ERK than natLDL (twofold).

Conclusions: This study demonstrates the following: (i) both natLDL and hypochlorite-oxidized LDL utilize ERK pathway to mediate aldosterone release; (ii) mildly oxidized LDL sensitizes the adrenocortical cells to further stimulations by Ang II similar to natLDL that may have a role in pathological processes; (iii) extensive LDL oxidation counteracts adrenocortical aldosterone release.

MeSH terms

  • Adrenal Cortex / drug effects
  • Adrenal Cortex / metabolism
  • Adrenal Glands / drug effects*
  • Adrenal Glands / metabolism*
  • Aldosterone / metabolism*
  • Angiotensin II / pharmacology
  • Blotting, Western
  • Cell Line
  • Dose-Response Relationship, Drug
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Humans
  • Hypochlorous Acid / chemistry
  • Lipoproteins, LDL / chemistry*
  • Lipoproteins, LDL / pharmacology*
  • Oxidants / chemistry
  • RNA / biosynthesis
  • RNA / isolation & purification
  • Receptors, LDL / drug effects
  • Receptors, LDL / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Steroids / biosynthesis
  • Stimulation, Chemical
  • Thiobarbituric Acid Reactive Substances / metabolism

Substances

  • Lipoproteins, LDL
  • Oxidants
  • Receptors, LDL
  • Steroids
  • Thiobarbituric Acid Reactive Substances
  • oxidized low density lipoprotein
  • Angiotensin II
  • Aldosterone
  • RNA
  • Hypochlorous Acid
  • Extracellular Signal-Regulated MAP Kinases